Mengqi Shi

机构：National University of Singapore, Shaoxing People's Hospital · ORCID：0000-0002-8379-5202

发表论文 14 篇 · 总被引 615 次 · h-index 8

代表论文

• Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy (2020 · Molecular Therapy — Nucleic Acids · 被引 252)
• Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics (2021 · Theranostics · 被引 140)
• Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [ 68 Ga]Ga-FAPI-RGD (2022 · Theranostics · 被引 88)
• Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists (2022 · Frontiers in Medicine · 被引 62)
• Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03 (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 21)
• C-Terminal Domains of Spider Silk Proteins Having Divergent Structures but Conserved Functional Roles (2022 · Biomacromolecules · 被引 16)